LLY

751.96

-3.18%↓

JNJ

155.56

-1.06%↓

UNH

385.73

-1.37%↓

ABBV

185.44

-1.29%↓

ABT

133.82

-0.01%↓

LLY

751.96

-3.18%↓

JNJ

155.56

-1.06%↓

UNH

385.73

-1.37%↓

ABBV

185.44

-1.29%↓

ABT

133.82

-0.01%↓

LLY

751.96

-3.18%↓

JNJ

155.56

-1.06%↓

UNH

385.73

-1.37%↓

ABBV

185.44

-1.29%↓

ABT

133.82

-0.01%↓

LLY

751.96

-3.18%↓

JNJ

155.56

-1.06%↓

UNH

385.73

-1.37%↓

ABBV

185.44

-1.29%↓

ABT

133.82

-0.01%↓

LLY

751.96

-3.18%↓

JNJ

155.56

-1.06%↓

UNH

385.73

-1.37%↓

ABBV

185.44

-1.29%↓

ABT

133.82

-0.01%↓

Inicio・Lista de Acciones・Avalo Therapeutics

A
Avalo Therapeutics

Cerrado

4.27 -3.17

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

4.25

Máximo

4.45

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 meses	+666.21% upside

Dividendos
By Dow Jones
Próximas Ganancias	12 may 2025

Avalo Therapeutics Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

8 may 2025, 23:59 UTC

Principales Noticias

Ganancias

Naver 1Q Net Slumps on Higher Costs

8 may 2025, 23:39 UTC

Ganancias

OCBC 1Q Net Down on Lower Interest Income

8 may 2025, 23:01 UTC

Ganancias

Macquarie Raises Dividend After 5.5% Rise in Annual Profit -- Update

8 may 2025, 22:52 UTC

Ganancias

REA Expects Annual Listings Growth Despite April Decline

8 may 2025, 22:46 UTC

Ganancias

Macquarie Raises Dividend After 5.5% Rise in Annual Profit

8 may 2025, 23:45 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

8 may 2025, 23:45 UTC

Charlas de Mercado

Nikkei May Rise as Tariffs Fears Ease -- Market Talk

8 may 2025, 23:41 UTC

Charlas de Mercado

Gold Rises on Possible Technical Recovery; Gains May be Capped by Risk-on Mood -- Market Talk

8 may 2025, 23:30 UTC

Ganancias

Itau Unibanco 1Q Rev BRL45.02B >ITUB

8 may 2025, 23:29 UTC

Ganancias

Itau Unibanco 1Q EPS BRL1.03 >ITUB

8 may 2025, 23:22 UTC

Ganancias

Naver 1Q Net Profit Largely Met FactSet-Compiled Consensus

8 may 2025, 23:22 UTC

Ganancias

Naver 1Q Net KRW423.70B Vs. Net KRW555.80B >035420.SE

8 may 2025, 23:21 UTC

Ganancias

Naver 1Q Oper Pft KRW505.30B Vs. Pft KRW439.30B >035420.SE

8 may 2025, 23:21 UTC

Ganancias

Naver 1Q Rev KRW2.787T Vs. KRW2.526T >035420.SE

8 may 2025, 23:17 UTC

Ganancias

Oversea-Chinese Banking Corp. 1Q Net Interest Income S$2.35B Vs. S$2.44B >O39.SG

8 may 2025, 23:17 UTC

Ganancias

Oversea-Chinese Banking Corp. 1Q Total Income S$3.66B Vs. S$3.63B >O39.SG

8 may 2025, 23:17 UTC

Ganancias

Oversea-Chinese Banking Corp. 1Q Net S$1.88B Vs. Net S$1.98B >O39.SG

8 may 2025, 23:05 UTC

Charlas de Mercado

ANZ Could Cut Dividend by 10% From 2H -- Market Talk

8 may 2025, 23:05 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

8 may 2025, 23:01 UTC

Principales Noticias

With U.K. Deal, U.S. Signals That 10% Tariff on World Is New Baseline -- WSJ

8 may 2025, 22:28 UTC

Ganancias

REA Expects FY 2025 Listings Growth of 1-2%

8 may 2025, 22:28 UTC

Ganancias

REA Says April Listings Decline Reflects Year Ago Strength, Timing of Easter and Election

8 may 2025, 22:27 UTC

Ganancias

REA Says April Sydney, Melbourne Listings Both Down 16% on Year

8 may 2025, 22:27 UTC

Ganancias

REA Says April Residential Listings Fell by 11% on Year

8 may 2025, 22:26 UTC

Ganancias

REA 3Q Operating Expenses A$176 Million, Up 12% on Year

8 may 2025, 22:26 UTC

Ganancias

REA 3Q Free Cash Flow A$132 Million, Up 19% on Year

8 may 2025, 22:26 UTC

Ganancias

REA 3Q Operating Ebitda A$199 Million, Up 12% on Year

8 may 2025, 22:26 UTC

Ganancias

REA Nine-Months Free Cash Flow A$389 Million, Up 21% on Year

8 may 2025, 22:25 UTC

Ganancias

REA Nine-Months Operating Expenses A$513 Million, Up 15% on Year

8 may 2025, 22:25 UTC

Ganancias

REA Nine-Months Operating Ebitda A$734 Million, Up 19% on Year

Comparación entre iguales

Cambio de precio

Avalo Therapeutics Esperado

Precio Objetivo

By TipRanks

666.21% repunte

Estimación a 12 meses

Media 33.33 USD 666.21%

Máximo 48 USD

Mínimo 18 USD

De acuerdo con 7 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Avalo Therapeutics Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

7 ratings

Comprar

Mantener

Vender

De acuerdo con 7 analistas que ofrecen calificaciones bursátiles a para Avalo Therapeutics Dist en los últimos 3 meses.

Finanzas

Otras acciones del sector

LLY

Eli Lilly and Co.

751.96

↓-3.18%

JNJ

Johnson and Johnson

155.56

↓-1.06%

UNH

UnitedHealth Group Inc

385.73

↓-1.37%

ABBV

AbbVie Inc

185.44

↓-1.29%

ABT

Abbott Laboratories

133.82

↓-0.01%

A Avalo Therapeutics

Resumen

Variación precio

Recomendaciones

Dividendos

Avalo Therapeutics Gráfico

Noticias Relacionadas

Comparación entre iguales

Avalo Therapeutics Esperado

Precio Objetivo

Consenso

Finanzas

Otras acciones del sector

A
Avalo Therapeutics